STERIS plc (NYSE:STE) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp cut its holdings in shares of STERIS plc (NYSE:STE) by 2.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 621,447 shares of the medical equipment provider’s stock after selling 13,915 shares during the quarter. Bank of New York Mellon Corp owned 0.63% of STERIS worth $127,745,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Ashton Thomas Securities LLC purchased a new stake in shares of STERIS in the 3rd quarter valued at approximately $25,000. Human Investing LLC purchased a new stake in shares of STERIS in the 4th quarter valued at approximately $31,000. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares during the last quarter. Manchester Capital Management LLC increased its position in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Quarry LP purchased a new stake in shares of STERIS in the 3rd quarter valued at approximately $67,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

STE has been the topic of a number of recent analyst reports. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Stephens reissued an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler increased their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Trading Down 0.4 %

NYSE STE opened at $219.23 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The firm’s fifty day moving average price is $214.76 and its 200 day moving average price is $223.11. The company has a market capitalization of $21.54 billion, a price-to-earnings ratio of 46.54 and a beta of 0.84. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.